Physiomics will use its Virtual Tumour model technology to predict the ideal treatment regimens of VAL201 from ValiRx

Physiomics plc

U.K. / Tools, Services, and Manufacturing

$7.4m on 09/16/2011 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

ValiRx plc

U.K. / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced